Name /Cyclica Inc.
Address /207 Queens Quay W Suite 420, Toronto, ON M5J 1A7 Canada
Name /Verner de Biasi
Title /Chief Partnership Officer
Telephone /(Work) +1 416 670 4780
Mobile /+1 416 670 4780
Cyclica is the partner of choice for data-driven drug discovery. We advance molecules that embrace the complexity of disease. Our work spans dozens of collaborations with large pharma and biotech as well as 50 joint ventures and counting. We are a passionate team of biotech and pharma professionals, biologists, chemists, and computer scientists who live and labor at the intersection of our collective expertise.
Our computational approach to polypharmacology is unique in the industry. Screening for actives with target-specific black boxes has limited upside. Instead, we use a proteome-wide lens to evaluate multiple novel and rare on and off-target interactions simultaneously. We can even work with non-human proteomes.
We’re also the only company of our kind that integrates science to advance molecules downstream. A structure-based view keeps our work accountable to biology, chemistry, physics, and genomics. After all, not all hits are created equal. Basic pathway analysis isn’t nearly enough. Our commitment to collaborating holistically improves the odds of reaching milestones dramatically.
For our large biotech and pharma customers, we help enrich existing portfolios, building custom models that deliver IP-grade, proprietary insights with breakthrough efficiency and precision. Separately, across a portfolio of more than 50 joint ventures and growing, we work at the vanguard of a wide variety of therapeutic areas to help get new medicines to patients faster and more precisely.
We are a team of biotech and pharma professionals, biologists, chemists, and computer scientists who live and labor at the intersection of our collective expertise. We’ve walked in your shoes for decades, and we’d love to help advance your impact.
To learn more about Cyclica and how we partner, please visit www.cyclicarx.com
Name /Arthur Li